AGT Newsroom Press Releases

Published on March 25, 2019 - 17:00 GMT

AGT Launches Oncology Science Advisory Group to Accelerate Research For A Cancer Cure

ROCKVILLE, MD, UNITED STATES, March 25, 2019 /⁨EINPresswire.com⁩/ -- American Gene Technologies (AGT), a leading gene and cell therapy biotech company based in Rockville, Md., has established an advisory group for the advancement of immunotherapies that …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 21, 2019 - 13:45 GMT

AGT Granted Fifth Patent Protecting Its Immunotherapy Cancer Cure Asset

ROCKVILLE, MD, UNITED STATES, March 21, 2019 /⁨EINPresswire.com⁩/ -- American Gene Technologies (AGT) recently was awarded a fifth immuno-oncology patent (“Methods and Composition for the Activation of Gamma Delta T cells” US10137144) to protect its lead …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 9, 2019 - 01:08 GMT

Second Patient Cured of HIV and The Implications for American Gene Technologies's AGT103-T

ROCKVILLE, MD, UNITED STATES, March 8, 2019 /⁨EINPresswire.com⁩/ -- American Gene Technologies (AGT) is pleased to see the release of information about a second individual cured of HIV in London--recently reported in the Wall Street Journal and New York …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 14, 2019 - 15:11 GMT

American Gene Technologies Signs Research Agreement with NIAID for Experimental HIV/AIDS Cure Strategy

AGT signed Research Collaboration Agreement with National Institute of Allergy and Infectious Diseases for studies on AGT’s cell and gene therapy for HIV/AIDS. ROCKVILLE, MD, UNITED STATES, February 14, 2019 /⁨EINPresswire.com⁩/ -- American Gene …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on January 7, 2019 - 21:25 GMT

American Gene Technologies To Attend 2019 J.P. Morgan Healthcare Conference

ROCKVILLE, MD, UNITED STATES, January 7, 2019 /⁨EINPresswire.com⁩/ -- American Gene Technologies announced today that its Chief Executive Officer, Jeff Galvin, will attend the annual J.P. Morgan Healthcare Conference, held at the Westin St. Francis between …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on October 18, 2018 - 20:17 GMT

American Gene Technologies Granted FDA Orphan Drug Designation For Phenylketonuria

ROCKVILLE, MD, UNITED STATES, October 18, 2018 /⁨EINPresswire.com⁩/ -- American Gene Technologies (AGT), a leading gene and cell therapy company in the discovery and development of lentiviral vector based therapeutics, announces that the U.S. Food and Drug …

Distribution channels: Business & Economy, Companies ...
Published on September 26, 2018 - 18:17 GMT

AMERICAN GENE TECHNOLOGIES TO PRESENT AT 2018 CELL & GENE MEETING ON THE MESA

ROCKVILLE, MD, UNITED STATES, September 26, 2018 /⁨EINPresswire.com⁩/ -- American Gene Technologies announced today that its Chief Science Officer C. David Pauza, Ph.D. will present at the annual Partnering Forum, part of the Cell & Gene Meeting on the …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on September 6, 2018 - 15:25 GMT

IMMUNOTHERAPY CEO JEFF GALVIN JOINS THE BOARD OF DIRECTORS OF THE CANCER SUPPORT COMMUNITY

ROCKVILLE, MD, UNITED STATES, September 6, 2018 /⁨EINPresswire.com⁩/ -- Jeff Galvin, a former Silicon Valley CEO, and now a leader in the field of gene and cell therapy to cure cancer and other human diseases, has joined the Board of Directors of the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 22, 2018 - 15:30 GMT

AMERICAN GENE TECHNOLOGIES (AGT) GRANTED THREE NEW PATENTS IN ITS HIV CURE AND IMMUNO-ONCOLOGY PROGRAMS

Expected HIV Cure Clinical Trial To Begin in 2019 ROCKVILLE, MD, UNITED STATES, August 22, 2018 /⁨EINPresswire.com⁩/ -- AGT announces the receipt of three foundational patents. Two new patents focus on the immuno-oncology program and add to AGT’s broad …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 20, 2018 - 15:20 GMT

AMERICAN GENE TECHNOLOGIES CEO JEFF GALVIN JOINS MARYLAND TECH COUNCIL BOARD OF DIRECTORS

ROCKVILLE, MD, UNITED STATES, August 20, 2018 /⁨EINPresswire.com⁩/ -- American Gene Technologies International Inc. (AGT)’s CEO and founder Jeff Galvin has been appointed to the Board of Directors of the Maryland Tech Council, the largest Maryland …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on January 31, 2018 - 13:00 GMT

AMERICAN GENE TECHNOLOGIES ANNOUNCES PROGRESS TOWARD PHASE I CLINICAL TRIAL OF AGT103-T FOR HIV FUNCTIONAL CURE

Completes process development for the AGT103-T automated cell manufacturing protocol ROCKVILLE, MD, USA, January 31, 2018 /EINPresswire.com/ -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on September 25, 2017 - 19:18 GMT

AMERICAN GENE TECHNOLOGIES BUILDS MONTGOMERY COUNTY GENE & CELL THERAPY MOMENTUM

Fast Growing Maryland Biotech Company Moves to a 24,000 Sq. Ft. Location and Will Host Ribbon Cutting Ceremony on October 23, 2017 ROCKVILLE, MD, UNITED STATES, September 25, 2017 /EINPresswire.com/ -- American Gene Technologies (AGT), a private Maryland …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Contact

Sasha Whitaker
American Gene Technologies
202-997-2626

email us here

Share This Newsroom

Facebook Twitter LinkedIn

Company/Organization

American Gene Technologies International
9640 Medical Center Dr.
Rockville, Maryland, 20850
United States
301-337-2100

About

AGT is an emerging gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications including: large and orphan indications, infectious disease, immune-oncology, and monogenic disorders. AGT expects to take its patented, lead candidate for an HIV Cure into the clinic in 2019. It has pioneered a novel immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack a variety of cancers. Four key patents in AGT’s novel immuno-oncology approach have been granted. AGT has a diverse portfolio of patent filings surrounding key tools and components in viral vectors, gene therapy, and regenerative medicine.

https://www.americangene.com/

The Newsroom of American Gene Technologies International